Roundtable Discussion: The New Frontiers of Risk: Potency, Toxicology, & Occupational Safety in Emerging Biopharma Modalities
- How can we modernise risk assessment frameworks to manage uncertainty in potency and toxicology for novel compounds, where data are sparse or still evolving?
- What methodologies, from flexible banding systems to pre-approved dynamic risk assessments, best support safe, agile decision-making in R&D environments?
- How can toxicologists, EHS professionals, and process scientists collaborate to close data gaps and translate incomplete toxicology findings into practical workplace safeguards?